SYNDAX PHARMACEUTICALS INC
SNDX·87164F105·US·Common Stock·Healthcare - Biotechnology-13D/G
SNDX (SYNDAX PHARMACEUTICALS INC) is held by 131 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($197.2M), GOLDMAN SACHS GROUP INC ($128.1M), STATE STREET CORP ($123.7M). Net institutional sentiment: Mixed.
131
Holders
(11 Elite)
$1.5B
Total Value
53% (137)
Consensus
72 buying - 65 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 27, 2026 · Insiders Jun 12, 2026 · Activists Aug 7, 2026 · Congress none
InsiderBABotwood Nicholas A.J.Exercise 31K shJun 12, 2026
InsiderBABotwood Nicholas A.J.Sell $567KJun 12, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 146
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer